Back to the WireSeeking Alpha
ConfirmedSeeking Alpha ·
Bausch + Lomb post-surgical ocular pain asset fails phase 2 main goal
Bausch + Lomb reported that its post-surgical ocular pain asset failed to meet the main goal of a phase 2 trial. The result is a setback for the pipeline and a point of interest for holders of the stock.
Comments
Log in or create a free account to comment.
No comments yet.
The headline links to the original source; the summary is written by The Market Standard. Nothing here is financial advice.